Advertisement

Atherosclerotic Plaque Characterisation by Imaging

  • S. P. S. Howarth
  • J. U. King-Im
  • J. H. Gillard
Chapter
  • 972 Downloads

Abstract

Carotid artery stenosis is known to be a significant risk factor for stroke and indeed extracranial atheroma is the single most important contributor to non-haemorrhagic stroke in the developed world. Studies such as the European Carotid Surgery Trial (ECST) [63], [11] and North American Symptomatic Carotid Endarterectomy Trial (NASCET) [25], despite some methodological differences, demonstrated a significant benefit for endarterectomy in symptomatic carotid stenosis of more than 70%. More recently, evidence has been published in the form of the Asymptomatic Carotid Surgery Trial (ACST) [34], that intervention in the asymptomatic population with a stenosis of 70% or more may be of benefit providing the associated risks and likely morbidity of the intervention is low.

Keywords

Carotid Stenosis Carotid Plaque Lipid Core Plaque Morphology Symptomatic Carotid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Anzai Y, Piccoli CW, Outwater EK et al.: Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228: 777–788 (2003).PubMedGoogle Scholar
  2. [2]
    Anzai Y: Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 15: 103–111 (2004).PubMedCrossRefGoogle Scholar
  3. [3]
    Arapoglou B, Kondi-Pafiti A, Katsenis K et al.: The clinical significance of carotid plaque haemorrhage. Int Angiol 13: 323–326 (1994).PubMedGoogle Scholar
  4. [4]
    Baldewsing RA, Schaar JA, Mastik F et al.: Assessment of vulnerable plaque composition by matching the deformation of a parametric plaque model to measured plaque deformation. IEEE Trans Med Imaging 24: 514–528 (2005).PubMedCrossRefGoogle Scholar
  5. [5]
    Bang OY, Lee PH, Yoon SR et al.: Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 76: 1128–1134 (2005).PubMedCrossRefGoogle Scholar
  6. [6]
    Bellin MF, Beigelman C, Precetti-Morel S: Iron oxideenhanced MR lymphography: initial experience. Eur J Radiol 34: 257–264 (2000).PubMedCrossRefGoogle Scholar
  7. [7]
    Bennett MR, Boyle JJ: Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138: 3–9 (1998).PubMedCrossRefGoogle Scholar
  8. [8]
    Cai H, Song C, Lim IG et al.: Importance of C-reactive protein in regulating monocyte tissue factor expression in patients with inflammatory rheumatic diseases. J Rheumatol 32: 1224–1231 (2005).PubMedGoogle Scholar
  9. [9]
    Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators. Stroke 22: 816–817 (1991).Google Scholar
  10. [10]
    Dousset V, Ballarino L, Delalande C et al.: Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR 20: 223–227 (1999).PubMedGoogle Scholar
  11. [11]
    Ferro JM, Oliveira V, Melo TP et al.: Role of endarterectomy in the secondary prevention of cerebrovascular accidents: results of the European Carotid Surgery Trial (ECST). Acta Med Port 4: 227–228 (1991).PubMedGoogle Scholar
  12. [12]
    Flacke S, Fischer S, Scott MJ et al.: Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104: 1280–1285 (2001).PubMedGoogle Scholar
  13. [13]
    Fleige G, Seeberger F, Laux D et al.: In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest Radiol 37:482–488 (2002).PubMedCrossRefGoogle Scholar
  14. [14]
    Gori AM, Corsi AM, Fedi S et al.: A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82: 335–341 (2005).PubMedGoogle Scholar
  15. [15]
    Hatsukami TS, Ross R, Polissar NL et al.: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102:959–964 (2000).PubMedGoogle Scholar
  16. [16]
    Heller EA, Liu E, Tager AM et al.: Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112: 578–586 (2005).PubMedCrossRefGoogle Scholar
  17. [17]
    JM UK-I, Trivedi RA, Sala E et al.: Evaluation of carotid stenosis with axial high-resolution black-blood MR imaging. Eur Radiol 14: 1154–1161 (2004).Google Scholar
  18. [18]
    Jude B, Zawadzki C, Susen S et al.: Relevance of tissue factor in cardiovascular disease. Arch Mal Coeur Vaiss 98: 667–671 (2005).PubMedGoogle Scholar
  19. [19]
    Kanno S, Wu YJ, Lee PC et al.: Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104: 934–938 (2001).PubMedGoogle Scholar
  20. [20]
    Karatzis EN: The role of inflammatory agents in endothelial function and their contribution to atherosclerosis. Hell J Cardiol 46: 232–239 (2005).Google Scholar
  21. [21]
    Kawamata T, Okada Y, Kondo S et al.: Extravascular application of an intravascular ultrasound (IVUS) catheter during carotid endarterectomy to verify distal ends of stenotic lesions. Acta Neurochir (Wien) 146:1205–1209 (2004).CrossRefGoogle Scholar
  22. [22]
    Kelly J, Hunt BJ, Moody A: Magnetic resonance direct thrombus imaging: a novel technique for imaging venous thromboemboli. Thromb Haemost 89: 773–782 (2003).PubMedGoogle Scholar
  23. [23]
    Kerwin W, Hooker A, Spilker M et al.: Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107: 851–856 (2003).PubMedCrossRefGoogle Scholar
  24. [24]
    Kim JY, Harisinghani MG: MR imaging staging of pelvic lymph nodes. Magn Reson Imaging Clin N Am 12: 581–586 (2004).PubMedCrossRefGoogle Scholar
  25. [25]
    Kita MW: Carotid endarterectomy in symptomatic carotid stenosis: NASCET comparative results at 30 months of follow-up. J Insur Med 24: 42–46 (1992).PubMedGoogle Scholar
  26. [26]
    Kooi ME, Cappendijk VC, Cleutjens KB et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107: 2453–2458 (2003).PubMedCrossRefGoogle Scholar
  27. [27]
    Laberge MA, Moore KJ, Freeman MW: Atherosclerosis and innate immune signaling. Ann Med 37: 130–140 (2005).PubMedCrossRefGoogle Scholar
  28. [28]
    Lendon CL, Davies MJ, Born GV et al.: Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 87:87–90 (1991).PubMedCrossRefGoogle Scholar
  29. [29]
    Littlewood TD, Bennett MR: Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14: 469–475 (2003).PubMedCrossRefGoogle Scholar
  30. [30]
    Loree HM, Kamm RD, Stringfellow RG et al.: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 71: 850–858 (1992).PubMedGoogle Scholar
  31. [31]
    Mauriello A, Sangiorgi G, Fratoni S et al.: Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 45: 1585–1593 (2005).PubMedCrossRefGoogle Scholar
  32. [32]
    McCarthy MJ, Loftus IM, Thompson MM et al.: Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 30: 261–268 (1999).PubMedCrossRefGoogle Scholar
  33. [33]
    McCarthy MJ, Loftus IM, Thompson MM et al.: Vascular surgical society of great britain and ireland: angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology. Br J Surg 86: 707–708 (1999).PubMedCrossRefGoogle Scholar
  34. [34]
    Mohammed N, Anand SS: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. MRC asymptomatic carotid surgery trial (ACST) collaborative group. Lancet 363: 1491–502 (2004), Vasc Med 10: 77–78 (2005).CrossRefGoogle Scholar
  35. [35]
    Moody AR, Murphy RE, Morgan PS et al.: Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107: 3047–3052 (2003).PubMedCrossRefGoogle Scholar
  36. [36]
    Moody AR: Magnetic resonance direct thrombus imaging. J Thromb Haemost 1: 1403–1409 (2003).PubMedCrossRefGoogle Scholar
  37. [37]
    Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85: 1–31 (2005).PubMedCrossRefGoogle Scholar
  38. [38]
    Nicolaides AN, Kakkos SK, Griffin M et al.: Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 30: 275–284 (2005).PubMedCrossRefGoogle Scholar
  39. [39]
    Nissen SE, Gurley JC, Grines CL et al.: Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 84: 1087–1099 (1991).PubMedGoogle Scholar
  40. [40]
    Pasqui AL, Bova G, Maffei S et al.: Immune factors in atherosclerosis. Ann Ital Med Int 20: 81–89 (2005).PubMedGoogle Scholar
  41. [41]
    Porsche C, Walker L, Mendelow AD et al.: Assessment of vessel wall thickness in carotid atherosclerosis using spiral CT angiography. Eur J Vasc Endovasc Surg 23: 437–440 (2002).PubMedCrossRefGoogle Scholar
  42. [42]
    Porsche C, Walker L, Mendelow D et al.: Evaluation of cross-sectional luminal morphology in carotid atherosclerotic disease by use of spiral CT angiography. Stroke 32: 2511–2515 (2001).PubMedGoogle Scholar
  43. [43]
    Raynal I, Prigent P, Peyramaure S et al.: Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39: 56–63 (2004).PubMedCrossRefGoogle Scholar
  44. [44]
    Rudd JH, Warburton EA, Fryer TD et al.: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105: 2708–2711 (2002).PubMedCrossRefGoogle Scholar
  45. [45]
    Saini S, Sharma R, Baron RL et al.: Multicentre doseranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol 55: 690–695 (2000).PubMedCrossRefGoogle Scholar
  46. [46]
    Schmeisser A, Marquetant R, Illmer T et al.: The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 178:83–94 (2005).PubMedCrossRefGoogle Scholar
  47. [47]
    Sirol M, Itskovich VV, Mani V et al.: Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 109:2890–2896 (2004).PubMedCrossRefGoogle Scholar
  48. [48]
    Slager CJ, Wentzel JJ, Schuurbiers JC et al.: True 3-dimensional reconstruction of coronary arteries in patients by fusion of angiography and IVUS (ANGUS) and its quantitative validation. Circulation 102: 511–516 (2000).PubMedGoogle Scholar
  49. [49]
    Staikov IN, Arnold M, Mattle HP et al.: Comparison of the ECST, CC, and NASCET grading methods and ultrasound for assessing carotid stenosis. European Carotid Surgery Trial. North American Symptomatic Carotid Endarterectomy Trial. J Neurol 247: 681–686 (2000).PubMedCrossRefGoogle Scholar
  50. [50]
    Stary HC, Chandler AB, Dinsmore RE et al.: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355–1374 (1995).PubMedGoogle Scholar
  51. [51]
    Stehbens WE: The fatigue hypothesis of plaque rupture and atherosclerosis. Med Hypotheses 58: 359–360 (2002).PubMedCrossRefGoogle Scholar
  52. [52]
    Stintzing S, Heuschmann P, Barbera L et al.: Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann Vasc Surg 19: 310–319 (2005).PubMedCrossRefGoogle Scholar
  53. [53]
    Stoneman VE, Bennett MR: Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) 107: 343–354 (2004).PubMedCrossRefGoogle Scholar
  54. [54]
    Sun L, Wei LX, Shi HY et al.: Angiogenesis in coronary atherosclerotic plaques and its relationship to plaque stabilization. Zhonghua Bing Li Xue Za Zhi 32:427–431 (2003).PubMedGoogle Scholar
  55. [55]
    Tang D, Yang C, Kobayashi S et al.: Effect of a lipid pool on stress/strain distributions in stenotic arteries: 3-D fluid-structure interactions (FSI) models. J Biomech Eng 126: 363–370 (2004).PubMedCrossRefGoogle Scholar
  56. [56]
    Tang D, Yang C, Kobayashi S et al.: Effect of stenosis asymmetry on blood flow and artery compression: a three-dimensional fluid-structure interaction model. Ann Biomed Eng 31: 1182–1193 (2003).PubMedCrossRefGoogle Scholar
  57. [57]
    Trivedi RA, J UK-I, Graves MJ et al.: Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 28: 207–213 (2004).PubMedGoogle Scholar
  58. [58]
    Trivedi RA, JM UK-I, Graves MJ et al.: In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35:1631–1635 (2004).PubMedCrossRefGoogle Scholar
  59. [59]
    Trivedi RA, JM UK-I, Graves MJ et al.: MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46: 738–743 (2004).PubMedCrossRefGoogle Scholar
  60. [60]
    Trivedi RA, JM UK-I, Graves MJ et al.: Noninvasive imaging of carotid plaque inflammation. Neurology 63:187–188 (2004).PubMedGoogle Scholar
  61. [61]
    U-King-Im JM T R, Higgins N, Cross JJ et al.: Characterisation of carotid atheroma in symptomatic and asymptomatic patients using gadolinium-enhanced MRI. European Congress of Radiology, Vienna (2005).Google Scholar
  62. [62]
    Wardlaw JM, Lewis S: Carotid stenosis measurement on colour Doppler ultrasound: Agreement of ECST, NASCET and CCA methods applied to ultrasound with intra-arterial angiographic stenosis measurement. Eur J Radiol (2005).Google Scholar
  63. [63]
    Warlow CP: Symptomatic patients: the European Carotid Surgery Trial (ECST). J Mal Vasc 18: 198–201 (1993).PubMedGoogle Scholar
  64. [64]
    Wasserman BA, Casal SG, Astor BC et al.: Wash-in kinetics for gadolinium-enhanced magnetic resonance imaging of carotid atheroma. J Magn Reson Imaging 21: 91–95 (2005).PubMedCrossRefGoogle Scholar
  65. [65]
    Wasserman BA, Smith WI, Trout HH 3rd et al.: Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 223:566–573 (2002).PubMedGoogle Scholar
  66. [66]
    Yamamoto K, Ikeda U, Shimada K: Role of mechanical stress in monocytes/macrophages: implications for atherosclerosis. Curr Vasc Pharmacol 1: 315–319 (2003).PubMedCrossRefGoogle Scholar
  67. [67]
    Yuan C, Beach KW, Smith LH Jr et al.: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 98:2666–2671 (1998).PubMedGoogle Scholar
  68. [68]
    Yuan C, Kerwin WS, Ferguson MS et al.: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 15: 62–67 (2002).PubMedCrossRefGoogle Scholar
  69. [69]
    Yuan C, Mitsumori LM, Beach KW et al.: Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 221: 285–299 (2001).PubMedGoogle Scholar
  70. [70]
    Yuan C, Mitsumori LM, Ferguson MS et al.: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104: 2051–2056 (2001).PubMedGoogle Scholar
  71. [71]
    Zhang QJ, Goddard M, Shanahan C et al.: Differential gene expression in vascular smooth muscle cells in primary atherosclerosis and in stent stenosis in humans. Arterioscler Thromb Vasc Biol 22: 2030–2036 (2002).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2007

Authors and Affiliations

  • S. P. S. Howarth
    • 1
  • J. U. King-Im
    • 1
  • J. H. Gillard
    • 1
  1. 1.University Department of Radiology and Department of NeurosurgeryAddenbrooke’s HospitalCambridgeUK

Personalised recommendations